Halozyme Therapeutics Inc (HALO)

[maumar]

Athena's "in likely the three cases you're referring to all of which had overall survival primary endpoints and we all know it's very difficult to win in those settings." perhaps makes some people feel halo is more confident PEG can have a positive effect in PFS than OS?

The only other two reasons I can think of for the drop are the three bleeding events in the trial with Keytruda and the basically flat bulk sales.